CUE

NASDAQ

Cue Biopharma

$24.53

-2.56 (-9.45%)

Institutional

528.8%

Insider

8.55%

Retail/Other

-437.3%

Shares Outstanding

4.0M

As of Jun 2026

Holder	Shares	%	Change
Bleichroeder LP	6.8M	7.0%	-
Catalytic Wealth RIA LLC	4.6M	4.7%	+1.2M
Vanguard Group Inc	3.0M	3.1%	-0.0M
Lion Point Capital, LP	2.2M	2.3%	+2.2M
Geode Capital Management, LLC	1.1M	1.1%	+0.3M
BOOTHBAY FUND MANAGEMENT, LLC	704K	0.7%	+0.1M
Robertson Stephens Wealth Management, LLC	478K	0.5%	-
BlackRock Inc	449K	0.5%	-
Texas Capital Bank Wealth Management Services Inc	441K	0.5%	+0.4M
ANGELES WEALTH MANAGEMENT, LLC	310K	0.3%	-

Last 24 months (3 insiders)

Shao-Lee Lin CHIEF EXECUTIVE OFFICER

327,537 shares

Awards (1)

Shares	Price	Value	Date	Remaining
327,537	-	$9,963,676*	2026-05-03	327,537

Pasha Sarraf Director

246,440 shares

Buys (5)

Shares	Price	Value	Date	Remaining
78,116	$0.31	$24,325	2025-12-30	246,440
4,229	$0.31	$1,308	2025-12-30	4,229
77,417	$0.30	$23,349	2025-12-30	323,857
77,148	$0.30	$23,168	2025-12-30	81,377
86,947	$0.32	$27,597	2025-12-30	168,324

Daniel R Passeri CHIEF EXECUTIVE OFFICER

164,578 shares

Buys (1)

Shares	Price	Value	Date	Remaining
30,000	$1.03	$30,900	2024-12-16	164,578

Last 24 months

Total Bought

353,857 shares

$130,647

Total Sold

0 shares

Net Shares

+353,857

Net Value

$+130,647

Activity by Insider

Name	Bought	Sold	Net Shares	Net Value
Pasha Sarraf Director	+323,857	-	+323,857	$+99,747
Daniel R Passeri CHIEF EXECUTIVE OFFICER	+30,000	-	+30,000	$+30,900

Net insider buying: 353,857 shares ($130,647) in last 12 months

STOCK Act Disclosures

No congressional trading data available for this ticker.

Congressional trading data is sourced from STOCK Act disclosures and may not be available for all tickers.

Based on public disclosures. Reporting errors by representatives are common. Disclosure deadlines are 45 days after transaction.